-
Market Movers: Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Hemispherx Biopharma (NYSEMKT:HEB), The Spectranetics Corporation (NASDAQ:SPNC), Pfizer Inc. (NYSE:PFE), Forward Industries (NASDAQ:FORD)
Itau Unibanco Holding SA (ADR) (NYSE:ITUB) begin trading ex-dividend on February 02, 2015. A cash dividend payment of $0.005737 per share is scheduled to be paid on March 12, 2015. On Wednesday shares of Itau Unibanco Holding SA (ADR) (NYSE:ITUB) closed at $12.94. Company’s sales growth for last 5 years was 14.60% and EPS growth…
-
Biotech Unusual Volume: Genetic Technologies Limited (NASDAQ:GENE), Hemispherx Biopharma (NYSEMKT:HEB), Esperion Therapeutics (NASDAQ:ESPR), Onconova Therapeutics (NASDAQ:ONTX), Ardelyx (NASDAQ:ARDX)
Genetic Technologies Limited (NASDAQ:GENE) on 29 January reported that it has entered into a A$24 million Standby Equity Placement Facility Agreement with the Kentgrove Capital Growth Fund to strengthen the Company’s funding position. On Tuesday shares of Genetic Technologies Limited (NASDAQ:GENE) closed at $3.09. Company’s sales growth for last 5 years was -16.50%. Hemispherx Biopharma,…
-
Watch 5 Stocks: Facebook Inc (NASDAQ:FB), Hemispherx Biopharma (NYSEMKT:HEB), Magna International (NYSE:MGA), Teekay LNG Partners (NYSE:TGP), Hannon Armstrong Sustnbl Infrstr Cap (NYSE:HASI)
Facebook Inc (NASDAQ:FB) on Friday updated its privacy policy to include additional provisions that give the social network even more power over the user data it can collect for commercial purposes, The Register reports. On Monday shares of Facebook Inc (NASDAQ:FB) closed at $74.99. Company’s sales growth for last 5 years was 74.20% and EPS…
-
Investor’s Alert: Xenon Pharmaceuticals Inc. (NASDAQ:XENE), Corning Inc. (NYSE:GLW), CIT Group Inc. (NYSE:CIT), Hemispherx Biopharma (NYSEMKT:HEB), General Mills (NYSE:GIS)
Canaccord Genuity reaffirmed their buy rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE) in a research note issued to investors on Tuesday, 13 January 2015. The firm currently has a $30.00 price target on the stock. On Friday shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) closed at $17.79. Company’s EPS growth for next 5 years is recorded…
-
Stock in News: Petroleo Brasileiro Petrobras (NYSE:PBR), California Resources Corporation (NYSE:CRC), Epizyme (NASDAQ:EPZM), Hemispherx Biopharma (NYSEMKT:HEB), The Dow Chemical Company (NYSE:DOW)
Brazil’s state-run oil company Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) on Tuesday named Joao Adalberto Elek Junior as its first head of governance, risk and compliance, part of efforts to ease investor concerns in the wake of a giant corruption scandal. On Tuesday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $6.78. Company’s…
-
Stocks to Keep Eyes On: QUALCOMM (NASDAQ:QCOM), Hemispherx Biopharma (NYSEMKT:HEB), The St. Joe (NYSE:JOE), Trina Solar (NYSE:TSL), Sirius XM. (NASDAQ:SIRI)
On January 2, All is not well for Qualcomm Inc. (NASDAQ:QCOM), the largest manufacturer of wireless chipsets globally, as the company may have to settle for lower royalty payment for its technology licensing in China. Over the last five years, Qualcomm has generated approximately $30.5 billion in licensing revenues. Bloomberg reported that the company was…
-
Notable Ups And Down: Huntington Bancshares Incorporated (NASDAQ:HBAN), First Solar (NASDAQ:FSLR), Hemispherx Biopharma (NYSEMKT:HEB), Misonix Inc. (NASDAQ:MSON), The Boeing (NYSE:BA)
On December 24, Acacia Research announced that its Unified Messaging Solutions subsidiary entered into a settlement and patent license agreement with Huntington Bancshares Incorporated (NASDAQ:HBAN). The agreement resolves litigation that was pending in the U.S. District Court for the Northern District of Illinois. Huntington Bancshares Incorporated (NASDAQ:HBAN) in last trading activity decreased -2.95% to close…
-
Keep Eyes on: Hemispherx Biopharma (NYSEMKT:HEB), Exelixis (NASDAQ:EXEL), AV Homes (NASDAQ:AVHI), The Dow Chemical Company (NYSE:DOW), General Cable (NYSE:BGC)
Hemispherx Biopharma, Inc. (NYSEMKT:HEB) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 2,218,758 shares, a decline of 28.4% from the November 28th total of 3,097,360 shares Hemispherx Biopharma, Inc. (NYSEMKT:HEB) in last trading activity increased 8.70% to close at…
-
What’s Hot: Hemispherx Biopharma (NYSEMKT:HEB), Advanced Micro Devices (NYSE:AMD), IntraLinks Holdings (NYSE:IL), Coronado Biosciences (NASDAQ:CNDO), Liquidity Services (NASDAQ:LQDT)
Hemispherx Biopharma, Inc. (NYSEMKT:HEB) announced on 9 December that it has received a new research report (dated December 5, 2014) from researchers at Howard University, Washington DC. The report describes a study in which Ampligen® (Poly I : Poly C12U) strongly inhibited the Ebola minigenome in the human embryonic kidney cell system. Hemispherx Biopharma, Inc.…
-
Watch 5 Stocks: CEMEX, S.A.B. (NYSE:CX), Hemispherx Biopharma (NYSEMKT:HEB), Arotech Corporation (NASDAQ:ARTX), Biogen Idec Inc. (NASDAQ:BIIB), Winnebago Industries (NYSE:WGO)
CEMEX, S.A.B. de C.V. (NYSE:CX) announced on 2 December the restart of the Tepeaca cement plant expansion. By 2017 the total production capacity will reach 7.6 million tons per year. Total investment is estimated to be approximately US$650 million.CEMEX, S.A.B. de C.V. (NYSE:CX) in last trading activity moved down -0.87% to close at $10.26. Company…